GSWM
CLVS

Golden State Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Golden State Wealth Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-200
Closed -$1K – 983
2020
Q1 		$1K Buy
+200
New +$1.6K ﹤0.01% 960

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Golden State Wealth Management's CLVS Position: Q2 2020 in Review

Golden State Wealth Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2020, closing a stake of 200 shares — an estimated $1K sold.

Golden State Wealth Management first reported a position in CLVS in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 158 funds tracked by Wall St. Rank hold CLVS as of Q2 2020.

  • Golden State Wealth Management reported no remaining Clovis Oncology, Inc. position as of Q2 2020 after selling out during the quarter.
  • Golden State Wealth Management sold 200 Clovis Oncology, Inc. shares in Q2 2020, an estimated $1K.
  • Golden State Wealth Management first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 1 quarter.
  • Golden State Wealth Management's Clovis Oncology, Inc. position peaked at $1K in Q1 2020.
  • 158 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2020.

Based on Golden State Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.